Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The main aim of this study is to compare the efficacy of short-course versus long-course
pre-operative chemotherapy with PAXG or mFOLFIRINOX in patients who receive a diagnosis of
pancreatic ductal adenocarcinoma (PDAC) resectable or borderline resectable.
Phase:
Phase 2
Details
Lead Sponsor:
Associazione Italiana per lo Studio del Pancreas
Collaborators:
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente High Research srl